Literature DB >> 10146902

Is there a need for an independent centre for pharmacoeconomics in the UK?

T Walley1, R T Edwards.   

Abstract

Mesh:

Year:  1994        PMID: 10146902     DOI: 10.2165/00019053-199405020-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  22 in total

1.  Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang?

Authors:  M Drummond
Journal:  Pharmacoeconomics       Date:  1992       Impact factor: 4.981

2.  Interpreting economic evaluations of medicines: a new role for the pharmacist? .

Authors:  A T Denby; N E Wells
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

3.  Regulation of the pharmaceutical industry and now pharmacoeconomic research?

Authors:  N E Wells
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

4.  Economic evaluation of pharmaceuticals: science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

5.  Where is the wisdom...?

Authors:  R Smith
Journal:  BMJ       Date:  1991-10-05

6.  The role of health economics.

Authors:  R Klein
Journal:  BMJ       Date:  1989-07-29

7.  Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.

Authors:  J Bradlow; A Coulter
Journal:  BMJ       Date:  1993-11-06

8.  The selected list.

Authors:  D N Bateman
Journal:  BMJ       Date:  1993-05-01

9.  General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method.

Authors:  M Maxwell; D Heaney; J G Howie; S Noble
Journal:  BMJ       Date:  1993-11-06

10.  Research and effective health care.

Authors: 
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

View more
  7 in total

1.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 2.  Drug rationing in the UK National Health Service. Current status and future prospects.

Authors:  T Walley; A Haycox; S Barton
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

Review 3.  Current prescribing in primary care in the UK. Effects of the indicative prescribing scheme and GP fundholding.

Authors:  T Walley; R Wilson; J Bligh
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

4.  Drugs, money and society (Part II).

Authors:  Tom Walley
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

5.  Drugs, money and society.

Authors:  T Walley
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

6.  Systems and strategies for managing the drugs budget in Glasgow.

Authors:  K Beard; E Forrester; A Lee; H Burns; M J Brodie
Journal:  BMJ       Date:  1998-11-14

7.  A purchaser perspective of managing new drugs: interferon beta as a case study.

Authors:  T Walley; S Barton
Journal:  BMJ       Date:  1995-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.